Ontolan, Esmeralda P.

HRN: 15-24-66  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/13/2025
12/20/2025
IV
500MG
Q8
PARTIAL MECHANICAL BOWEL OBSTRUCTION
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: